Document 0110
 DOCN  M9480110
 TI    Immunity to Haemophilus influenzae type b polysaccharide capsule in
       children with human immunodeficiency virus infection immunized with a
       single dose of Haemophilus vaccine.
 DT    9410
 AU    Peters VB; Sood SK; Department of Pediatrics, Mount Sinai School of
       Medicine, New; York, New York.
 SO    J Pediatr. 1994 Jul;125(1):74-7. Unique Identifier : AIDSLINE
       MED/94293133
 AB    We studied immunity to Haemophilus influenzae type b (Hib)
       polysaccharide capsule in 19 children infected with human
       immunodeficiency virus (HIV) immunized with a single dose of a Hib
       vaccine at a mean age of 28 months (range, 15 to 56 months). Four to
       eighty-five months after immunization, only 7 children (37%) were
       immune. There were no significant differences in the HIV classification
       of the Centers for Disease Control and Prevention, type of conjugate
       vaccine, age at vaccination or serologic testing, time from vaccination
       to antibody determination, and CD4 cell counts between children with and
       those without immunity.
 DE    Antibodies, Bacterial/*BLOOD  Bacterial Proteins/ADMINISTRATION &
       DOSAGE/*IMMUNOLOGY  Child, Preschool  Haemophilus influenzae/*IMMUNOLOGY
       Haemophilus Vaccines/ADMINISTRATION & DOSAGE/*IMMUNOLOGY  Human  HIV
       Infections/*IMMUNOLOGY  Infant  Polysaccharides,
       Bacterial/ADMINISTRATION & DOSAGE/*IMMUNOLOGY  Support, U.S. Gov't,
       P.H.S.  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).